4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-090052
Chief Executive Officer gave up 259,583 shares (to pay taxes)
- Chief Executive Officer acquired 450,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | 2024-07-31 | Option exercise | +450,000 | $3.29 | $1,480,500 | 798,811 | D: show line 1 in the form |
| BELANOFF JOSEPH K Chief Executive Officer | 2024-07-31 | Shares withheld for taxes | −259,583 | $38.67 | $10,038,075 | 539,228 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BELANOFF JOSEPH K Chief Executive Officer | 2024-07-31 | Option exercise · Stock option (right to buy) | −450,000 | 0 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…